Examination of factors influencing the racial disparity in fibroid incidence
Project Number1R01HD113709-01A1
Former Number1R01HD113709-01
Contact PI/Project LeaderHARRIS, HOLLY RUTH Other PIs
Awardee OrganizationFRED HUTCHINSON CANCER CENTER
Description
Abstract Text
PROJECT SUMMARY
Uterine fibroids are the most common pelvic tumors in women of reproductive age, coming to clinical
attention in one in four women. Fibroids are 2-3 times as common among Black women compared to White
women. Each year, fibroids result in $2.2 billion in health care costs and account for over 200,000
hysterectomies. Despite significant quality of life and health care costs associated with fibroids, few modifiable,
factors have been identified, and it is unknown why Black women are disproportionately affected. A major barrier
to understanding the relative contributions of established and yet-to-be identified risk factors that may contribute
to the fibroid disparity is that no single study has adequate numbers of both Black and White women to apply
advanced epidemiologic methods (e.g., mediation analyses, population attribute risks) to evaluate these
differences. Further, while an association between perceived interpersonal racism and fibroids has been shown,
no studies have examined the role of structural racism in fibroid incidence. We propose to study women from
two prospective U.S. cohorts — Black women from the Black Women’s Health Study (BWHS) and White women
from the Nurses’ Health Study II (NHSII) — to identify factors that explain the differences in fibroid incidence
between Black and White women. Among 59,000 participants (6,200+ newly diagnosed cases) in the BWHS
and 116,429 (8,100+ newly diagnosed cases) in the NHSII, we will examine the following specific aims:
Aim 1. Determine if established fibroid risk factors (e.g., parity, age at menarche, smoking, body size),
which differ in prevalence or timing between Black and White women, contribute to racial disparities in the risk
of uterine fibroids. We will calculate race-specific population attributable fractions to identify the proportion of
fibroids cases that are attributable to each risk factor and summarize the impact of differences in the
distribution of fibroids risk factors by race on fibroids incidence using a novel average odds ratio method.
Aim 2. Determine if environmental and neighborhood-level factors, including structural racism,
contribute to the racial disparities in the risk of uterine fibroids.
Aim 3. Estimate the contribution of multiple factors simultaneously to the fibroids incidence disparity
between Black and White women using multiple mediation analysis. Factors to be considered for inclusion into
the mediation models include reproductive, lifestyle, psychosocial, and environmental factors, and measures of
structural racism.
Given that more than 25% of women experience fibroids, the potential health and economic impact of
this novel study is substantial. Black women suffer disproportionately from fibroids, but the reasons for this
disparity are not understood. The identification factors that contribute to the racial disparity in fibroid incidence
could lay the groundwork for identifying strategies that would reduce fibroid incidence, particularly among Black
women.
Public Health Relevance Statement
PROJECT NARRATIVE
Fibroids are the most common pelvic tumors in women of reproductive age, incurring significant health care
costs and morbidity, and are two to three times as common among Black women compared to White women.
This study will seek to identify factors that explain the differences in fibroid incidence between Black and White
women. The identification of how established fibroid risk factors, psychosocial factors, environmental factors,
and structural racism contribute to the racial disparity in fibroid incidence could lay the groundwork for
identifying strategies that would reduce fibroid incidence, particularly among Black women.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
806433145
UEI
TJFZLPP6NYL6
Project Start Date
01-August-2024
Project End Date
30-April-2029
Budget Start Date
01-August-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$820,115
Direct Costs
$626,516
Indirect Costs
$193,599
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$820,115
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01HD113709-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01HD113709-01A1
Patents
No Patents information available for 1R01HD113709-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01HD113709-01A1
Clinical Studies
No Clinical Studies information available for 1R01HD113709-01A1
News and More
Related News Releases
No news release information available for 1R01HD113709-01A1
History
No Historical information available for 1R01HD113709-01A1
Similar Projects
No Similar Projects information available for 1R01HD113709-01A1